Fonte: Annals of Oncology. Nome do evento: European Society for Medical Oncology Congress - ESMO. Unidades: IME, ESALQ
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, E et al. Exposure to low energy amplitude modulated radiofrequency electromagnetic fields (EMF) is associated with rapid improvement in quality of life (QoL) status in patients with advanced hepatocellular carcinoma (HCC), using various analyses of EORTC-C30. Annals of Oncology. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1093/annonc/mdz261.006. Acesso em: 21 ago. 2024. , 2019APA
Santana, E., Costa, F. P., Setogute, Y., Carvalho, L., Lima, P., Sousa, M., et al. (2019). Exposure to low energy amplitude modulated radiofrequency electromagnetic fields (EMF) is associated with rapid improvement in quality of life (QoL) status in patients with advanced hepatocellular carcinoma (HCC), using various analyses of EORTC-C30. Annals of Oncology. Amsterdam: Elsevier. doi:10.1093/annonc/mdz261.006NLM
Santana E, Costa FP, Setogute Y, Carvalho L, Lima P, Sousa M, Gunz B, Azevedo F, Sabbaga J, Santos M, Biachi T, Jardim D, Freitas D, Horvat N, Otaviano R, Testagrossa L, Iemma AF, Silva FSC da, Tuszynski J. Exposure to low energy amplitude modulated radiofrequency electromagnetic fields (EMF) is associated with rapid improvement in quality of life (QoL) status in patients with advanced hepatocellular carcinoma (HCC), using various analyses of EORTC-C30 [Internet]. Annals of Oncology. 2019 ; 30 v663.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1093/annonc/mdz261.006Vancouver
Santana E, Costa FP, Setogute Y, Carvalho L, Lima P, Sousa M, Gunz B, Azevedo F, Sabbaga J, Santos M, Biachi T, Jardim D, Freitas D, Horvat N, Otaviano R, Testagrossa L, Iemma AF, Silva FSC da, Tuszynski J. Exposure to low energy amplitude modulated radiofrequency electromagnetic fields (EMF) is associated with rapid improvement in quality of life (QoL) status in patients with advanced hepatocellular carcinoma (HCC), using various analyses of EORTC-C30 [Internet]. Annals of Oncology. 2019 ; 30 v663.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1093/annonc/mdz261.006